A VISIONaerie™ approach
We discover, develop, and commercialize first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye
NEWSAerie Pharmaceuticals Announces Acceptance of Its Investigational New... Aerie Pharmaceuticals Announces Positive Topline Results of Netarsudil... Aerie Pharmaceuticals, Inc. Announces Drug Application for Regulatory...
Feb 19, 10:50 AM ET
52 - WEEK LOW/HIGH